---
type: "Symbol"
title: "T&K (301263.SZ) — 社區討論"
description: "該股票的社區討論，包括分析師觀點、財報解讀和投資策略，來自認證金融專業人士和活躍投資者。"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/301263.SZ/topics.md"
symbol: "301263.SZ"
parent: "https://longbridge.com/zh-HK/quote/301263.SZ.md"
count: 1
datetime: "2026-03-11T10:44:30.171Z"
locales:
  - [en](https://longbridge.com/en/quote/301263.SZ/topics.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/301263.SZ/topics.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/301263.SZ/topics.md)
---

# T&K (301263.SZ) — 社區討論

### [Taienkang's stock price breaks through the 40 yuan mark. Why does the 'miracle drug narrative' in the pharmaceutical field always work wonders?](https://longbridge.com/zh-HK/topics/31858495.md)

- 作者: [医药研究社](https://longbridge.com/zh-HK/profiles/15545088.md)
- 日期時間: 2025-07-16T12:28:36.000Z
- 評論: 0
- In the pharmaceutical sector, it is no longer unusual for a single product to send stock prices on a "roller coaster ride" and support a market cap of tens of billions. When a long-established

## 參考連結

- [T&K (301263.SZ)](https://longbridge.com/zh-HK/quote/301263.SZ.md)


> 支持的語言: [English](https://longbridge.com/en/quote/301263.SZ/topics.md) | [简体中文](https://longbridge.com/zh-CN/quote/301263.SZ/topics.md)